Answers are grounded in this paper and cite their sources.
The quadrivalent virus-like particle vaccine against human papillomavirus (QHPV) is a population vaccine targeting peri-pubertal girls and boys. Focus on evaluation of adolescent ovarian safety arises from cases in primary care and published case series describing the development of menstrual dysfunction and idiopathic premature ovarian insufficiency (POI) following QHPV vaccination.
No takes yet. Share an insight, caveat, or question.
Deirdre Therese Little (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: